Clinical Trial
CNS Tau Kinetics in Healthy Aging and Alzheimer's Disease
Study Description
“CNS Tau Kinetics in Healthy Aging and Alzheimer's Disease”
Alzheimer's disease (AD) is the most common cause of dementia and currently has no disease modifying treatments or simple accurate diagnostic tests. The goal of this project is to study how tau (a protein thought to cause AD) is made, transported and cleared in the human body. Better understanding of these processes may lead to improved understanding of AD, earlier diagnosis and a way to evaluate treatment.
Location
Methods
No pharmaceutical medication involved
Patients and healthy individuals accepted
L-Leucine 13C6
Additional Information
Official Study Title
CNS Tau Kinetics in Healthy Aging and Alzheimer's Disease
Clinical Trial ID
NCT03938870
ParticipAid ID
egJPrd
